FRED MacAULAY reckons he owes his long career to former Scotland boss Craig Brown dropping Ally McCoist from his World Cup ...

Better continence, erectile function, but data on oncologic outcomes still 2 years away ...

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.

When MRI offered no clear answer in suspected prostate cancer, the use of prostate-specific membrane antigen (PSMA)-PET/CT showed promise for reducing the number of biopsies without compromising the ...

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing ...

We’re prostate cancer experts. Here are the benefits of quick and targeted MRI scans - Urologists, radiologists and pathologists from Europe and the US agreed an “expert consensus statement” on prosta ...

Please provide your email address to receive an email when new articles are posted on . Pylarify TruVu is a new formulation of piflufolastat F 18 injection, which originally earned FDA approval in ...

Researchers highlighted that the global incidence of prostate cancer is projected to double over the next two decades, while increasing adoption of MRI-based diagnostic pathways may further increase ...

Active surveillance (AS) is an option for deferring or avoiding immediate treatment of low- to intermediate-risk prostate cancer by monitoring the disease to detect progression. Serial MRI enhances ...

Primary squamous cell carcinoma(SCC) of the prostate is a rare clinical condition, characterized by diagnostic challenges in the early stages, a high potential for metastasis, considerable malignancy, ...

The clinical impact of germline variants in DNA repair genes in patients who underwent curative surgery for localized prostate cancer. Multivariable logistic regression model for predicting ...